EWTX FY 2020 Earnings — Edgewise Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

EWTXEdgewise Therapeutics, Inc.

$3B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$185,000

Operating Income

-$17M

Net Income

-$17M

EPS (Diluted)

$-0.35

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$15M

Stock-Based Comp.

$354,000

Balance Sheet

Total Assets

$131M

Total Liabilities

$165M

Stockholders' Equity

-$33M

Cash & Equivalents

$105M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$185,000	-$123,000	-50.4%
Operating Income	-$17M	-$10M	-73.2%
Net Income	-$17M	-$9M	-79.8%